England sees record rise in late-stage prostate cancer diagnoses

A major national report has confirmed a startling surge in prostate cancer diagnoses across England, with numbers climbing by nearly 4,000 cases in a single year. Data from the National Prostate Cancer Audit reveals that 2025 saw a record-breaking 60,827 men diagnosed with the disease in England alone. That figure represents a seven per cent jump from the 57,029 cases recorded in 2024.

The situation is even more concerning when looking at late-stage detection. The audit shows that diagnoses of cancer which had already spread to other parts of the body are rising faster than overall numbers. These advanced cases increased by almost eleven per cent last year, moving from 5,696 in 2024 to 6,312 in 2025.

Yet there is a glimmer of hope within these grim statistics. An analysis involving more than 45,000 men with incurable advanced prostate cancer indicates survival rates have steadily improved over recent years. In 2015, fifty-six per cent of men died within three years of receiving an advanced diagnosis. By 2022 that number had dropped to forty-seven per cent, meaning more than half now survive past the three-year mark. Further research by the London School of Hygiene & Tropical Medicine found the risk of death from prostate cancer fell by nearly a quarter during this same period.

Experts credit these gains to treatment breakthroughs, specifically the wider adoption of chemotherapy, newer hormone therapies, and improved prostate radiotherapy methods. Despite these medical advances, prostate cancer has overtaken breast cancer to become the most common cancer in the UK today. More than 68,000 men receive a new diagnosis each year, which works out to one case every eight minutes.

However, the report also highlights deep inequalities in how patients are treated across England. Some specialist teams offer radical treatment to fewer than half of the men with aggressive prostate cancer, while others treat almost nine in ten. This disparity means access to care depends heavily on location and local resources.

Natalia Norori, head of data and evidence at Prostate Cancer UK, said far too many men are getting diagnosed only when options are limited because they are already at a later stage. She noted that the fact nearly half still die within three years remains a tragedy. With the number of people living with the disease continuing to climb, she argued it is vital to see investment in care so men can access treatments that improve quality of life and reduce side effects. This would allow them longer, happier years with their partners, family, and friends.

Professor Noel Clarke, clinical surgical lead for the NPCA, added that most men can be cured if the cancer is found early. He stressed that steps must be taken to ensure healthcare resources match this growing need. Early detection remains key to curing the disease.

These findings arrive just days after international researchers warned of a sharp rise in prostate cancer among younger men. NHS data shows diagnoses for men under fifty jumped from 158 cases in 2001 to 640 in 2023. Earlier this year, however, the UK National Screening Committee decided against population-wide screening. They concluded that potential harms outweighed the benefits of such a program.